Русские видео

Сейчас в тренде

Иностранные видео


Скачать с ютуб Can-Fite Biopharma, Ltd. (NYSE American: CANF) Investor Webinar - Oct. 29, 2024 в хорошем качестве

Can-Fite Biopharma, Ltd. (NYSE American: CANF) Investor Webinar - Oct. 29, 2024 1 день назад


Если кнопки скачивания не загрузились НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием, пожалуйста напишите в поддержку по адресу внизу страницы.
Спасибо за использование сервиса savevideohd.ru



Can-Fite Biopharma, Ltd. (NYSE American: CANF) Investor Webinar - Oct. 29, 2024

Can-Fite BioPharma is an advanced clinical stage drug development company with a platform of oral drugs designed to address multi-billion-dollar markets in the treatment of oncology and inflammatory diseases. The Company has 2 drug candidates in advanced stages of development, Piclidenoson for the treatment of psoriasis and Namodenoson for the treatment of advanced liver cancer. For each of the drugs, a registration plan has been agreed with both the U.S. FDA and the European Medicines Agency (EMA) and enrollment of patients for a pivotal Phase III clinical study is ongoing for liver cancer and underway for psoriasis. Namodenoson also has a robust anti-cancer effect against pancreatic cancer and a Phase IIa clinical study will be initiated in Q2 2024. Due to the liver-protective effect of Namodenoson, a Phase IIb study for the treatment NASH (MASH), is currently enrolling patients. Piclidenoson and Namodenoson have an excellent safety profile with experience in over 1,600 patients in clinical studies to date. Visit www.redchip.com/stocks/CANF to learn more.

Comments